Premier (NASDAQ:PINC) Updates FY 2025 Earnings Guidance

Premier (NASDAQ:PINC) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.260-1.340 for the period, compared to the consensus estimate of 1.290. The company issued revenue guidance of $940.0 million-$1.0 billion, compared to the consensus revenue estimate of $990.8 million.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on PINC. Robert W. Baird raised their price objective on Premier from $19.00 to $20.00 and gave the company a “neutral” rating in a report on Wednesday, November 6th. Canaccord Genuity Group increased their price objective on Premier from $19.00 to $21.00 and gave the company a “hold” rating in a research note on Wednesday, November 6th. Barclays upped their price target on shares of Premier from $20.00 to $24.00 and gave the company an “equal weight” rating in a report on Wednesday, November 6th. Finally, StockNews.com lowered shares of Premier from a “buy” rating to a “hold” rating in a report on Tuesday, November 5th. Ten analysts have rated the stock with a hold rating, According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $21.36.

Premier Stock Down 11.2 %

Shares of NASDAQ PINC traded down $2.51 on Tuesday, reaching $19.89. 517,385 shares of the company’s stock traded hands, compared to its average volume of 1,132,590. The business’s 50 day simple moving average is $21.91 and its two-hundred day simple moving average is $20.96. Premier has a 12 month low of $17.95 and a 12 month high of $23.56. The company has a market cap of $1.91 billion, a price-to-earnings ratio of 14.69 and a beta of 0.43.

Premier (NASDAQ:PINC) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.04). Premier had a net margin of 11.41% and a return on equity of 10.74%. Analysts forecast that Premier will post 1.12 earnings per share for the current fiscal year.

Premier Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Saturday, March 15th. Stockholders of record on Saturday, March 1st will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 4.22%. The ex-dividend date of this dividend is Friday, February 28th. Premier’s dividend payout ratio is currently 61.77%.

Insider Activity

In related news, CEO Michael J. Alkire sold 17,415 shares of Premier stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $23.16, for a total transaction of $403,331.40. Following the sale, the chief executive officer now owns 520,728 shares of the company’s stock, valued at approximately $12,060,060.48. This trade represents a 3.24 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Helen M. Boudreau sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $21.42, for a total value of $53,550.00. Following the completion of the transaction, the director now directly owns 20,668 shares in the company, valued at approximately $442,708.56. This represents a 10.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 59,425 shares of company stock valued at $1,320,242 in the last 90 days. 0.96% of the stock is currently owned by insiders.

About Premier

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.